D Kaul
Overview
Explore the profile of D Kaul including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
491
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thrombus or tumor? A case report of a rare sarcoma entity: intimal sarcoma of the pulmonary arteries
Dorr A, Florcken A, Bullinger L, Capper D, Deimling A, Kaul D, et al.
Mol Biol Rep
. 2024 Apr;
51(1):568.
PMID: 38656400
Background: Tumor embolism is a very rare primary manifestation of cancers and the diagnosis is challenging, especially if located in the pulmonary arteries, where it can mimic nonmalignant pulmonary embolism....
2.
Zoumplis A, Kolody B, Kaul D, Zheng H, Venepally P, McKnight D, et al.
ISME Commun
. 2023 Jan;
3(1):3.
PMID: 36690784
The meltwater streams of the McMurdo Dry Valleys are hot spots of biological diversity in the climate-sensitive polar desert landscape. Microbial mats, largely comprised of cyanobacteria, dominate the streams which...
3.
Dapper H, Belka C, Bock F, Budach V, Budach W, Christiansen H, et al.
Strahlenther Onkol
. 2021 Nov;
198(1):1-11.
PMID: 34786605
The new Medical Licensing Regulations 2025 (Ärztliche Approbationsordnung, ÄApprO) will soon be passed by the Federal Council (Bundesrat) and will be implemented step by step by the individual faculties in...
4.
Ostheimer C, Maurer M, Ebert N, Schmitt D, Krug D, Baumann R, et al.
Strahlenther Onkol
. 2021 Mar;
197(6):560-561.
PMID: 33674905
No abstract available.
5.
Brandes F, Striefler J, Dorr A, Schmiester M, Mardian S, Koulaxouzidis G, et al.
BMC Palliat Care
. 2021 Jan;
20(1):16.
PMID: 33446180
Background: Soft tissue sarcomas (STS) account for less than 1% of all malignancies. Approximately 50% of the patients develop metastases with limited survival in the course of their disease. For...
6.
Ostheimer C, Maurer M, Ebert N, Schmitt D, Krug D, Baumann R, et al.
Strahlenther Onkol
. 2021 Jan;
197(5):385-395.
PMID: 33410959
Background: In radical radiochemotherapy (RCT) of inoperable non-small-cell lung cancer (NSCLC) typical prognostic factors include T- and N-stage, while there are still conflicting data on the prognostic relevance of gross...
7.
Ramdas M, Sharma S, Kaul D, Bhatia A
J Trace Elem Med Biol
. 2018 Sep;
50:263-267.
PMID: 30262289
Chronic exposure of humans to inorganic arsenic as a potential risk for the incidence of diabetes has received wide attention. However, the biological mechanism through which arsenic plays a role...
8.
Anand A, Prabhakar S, Kaul D
Neurol India
. 2018 Mar;
46(4):256-260.
PMID: 29508816
Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are X- linked recessive disorders with the former following a severe and fatal course and the latter a milder clinical profile....
9.
Boning G, Kahn J, Kaul D, Rotzinger R, Freyhardt P, Pavel M, et al.
Acta Radiol
. 2017 Aug;
59(5):517-526.
PMID: 28786299
Background Frequent computed tomography (CT) follow-ups involve significant radiation related risks for patients with low-grade neuroendocrine tumors (NETs). Contrast agent (CA) application is essential for diagnostic evidence and has additional...
10.
Wani S, Kaul D, Mavuduru R, Kakkar N, Bhatia A
J Biotechnol
. 2017 Aug;
259:135-139.
PMID: 28764970
The global occurrence of prostate cancer with a range of patient outcome has prompted various investigators to explore novel molecular biomarkers that can precisely detect and track this type of...